Fulphila Subcutaneous and Lenvatinib Mesylate
Determining the interaction of Fulphila Subcutaneous and Lenvatinib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pegfilgrastim
Brand name: Fulphila, Neulasta, Neulasta Onpro Kit, Udenyca, Neulasta Delivery Kit
Synonyms: Fulphila, Fulphila Injection
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fulphila Subcutaneous-Lenvima
- Fulphila Subcutaneous-Lenvima (14 MG Daily Dose)
- Fulphila Subcutaneous-Lenvima (18 MG Daily Dose)
- Fulphila Subcutaneous-Lenvima (20 MG Daily Dose)
- Fulphila Subcutaneous-Lenvima (24 MG Daily Dose)
- Fulphila Subcutaneous-Lenvima (8 MG Daily Dose)
- Lenvatinib Mesylate-Fulvestrant
- Lenvatinib Mesylate-Fulvestrant Injection
- Lenvatinib Mesylate-Fulvestrant Intramuscular
- Lenvatinib Mesylate-Fulvicin P/G
- Lenvatinib Mesylate-Fulvicin-U/F
- Lenvatinib Mesylate-Fung-O Topical